{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:39:14Z","timestamp":1770061154516,"version":"3.49.0"},"reference-count":88,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2023.13946","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:14:43Z","timestamp":1688555683000},"source":"Crossref","is-referenced-by-count":4,"title":["Exploration of novel clusters and prognostic value of immune\u2011related signatures and identify HAMP as hub gene in colorectal cancer"],"prefix":"10.3892","volume":"26","author":[{"given":"Hongyuan","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Affiliated Dongguan People's Hospital of Southern Medical University, Dongguan, Guangdong 523009, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heling","family":"Dong","sequence":"additional","affiliation":[{"name":"School of Sports Education, Jinan University, Guangzhou, Guangdong 510632, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaofang","family":"Ren","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Organ Failure Research, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Affiliated Dongguan People's Hospital of Southern Medical University, Dongguan, Guangdong 523009, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Affiliated Dongguan People's Hospital of Southern Medical University, Dongguan, Guangdong 523009, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Health Management, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinfen","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Affiliated Dongguan People's Hospital of Southern Medical University, Dongguan, Guangdong 523009, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuefang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Affiliated Dongguan People's Hospital of Southern Medical University, Dongguan, Guangdong 523009, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"key20230807130259_b1-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20230807130259_b2-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","article-title":"Global patterns and trends in colorectal cancer incidence in young adults","volume":"68","author":"Siegel","year":"2019","journal-title":"Gut"},{"key":"key20230807130259_b3-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1245\/s10434-014-3982-1","article-title":"Survival paradox between stage IIB\/C (T4N0) and stage IIIA (T1-2N1) colon cancer","volume":"22","author":"Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"key20230807130259_b4-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2147\/IJGM.S277272","article-title":"The incidence rate of colorectal cancer in Saudi Arabia: An observational descriptive epidemiological analysis","volume":"13","author":"Almatroudi","year":"2020","journal-title":"Int J Gen Med"},{"key":"key20230807130259_b5-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fcell.2020.00514","article-title":"The diverse roles of the mucin gene cluster located on chromosome 11p15.5 in colorectal cancer","volume":"8","author":"Gan","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"key20230807130259_b6-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"1825178","DOI":"10.1080\/2162402X.2020.1825178","article-title":"Differential gene expression of tumor-infiltrating CD4+ T cells in advanced versus early stage colorectal cancer and identification of a gene signature of poor prognosis","volume":"9","author":"Sasidharan Nair","year":"2020","journal-title":"Oncoimmunology"},{"key":"key20230807130259_b7-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.3748\/wjg.v21.i22.7014","article-title":"Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go","volume":"21","author":"Ihn\u00e1t","year":"2015","journal-title":"World J Gastroenterol"},{"key":"key20230807130259_b8-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: A general overview and future perspectives in colorectal cancer","volume":"18","author":"M\u00e1rmol","year":"2017","journal-title":"Int J Mol Sci"},{"key":"key20230807130259_b9-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ctrv.2019.04.003","article-title":"Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy","volume":"76","author":"Ciardiello","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"key20230807130259_b10-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","article-title":"Colorectal cancer","volume":"375","author":"Cunningham","year":"2010","journal-title":"Lancet"},{"key":"key20230807130259_b11-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/1078-0432.CCR-11-1716","article-title":"Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer","volume":"18","author":"de Weger","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20230807130259_b12-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"key20230807130259_b13-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","article-title":"Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Benson","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"key20230807130259_b14-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/cancers12020319","article-title":"Prognostic and predictive molecular biomarkers for colorectal cancer: Updates and challenges","volume":"12","author":"Koncina","year":"2020","journal-title":"Cancers (Basel)"},{"key":"key20230807130259_b15-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"869","DOI":"10.12998\/wjcc.v6.i15.869","article-title":"Biomarkers in colorectal cancer: Current clinical utility and future perspectives","volume":"6","author":"Vacante","year":"2018","journal-title":"World J Clin Cases"},{"key":"key20230807130259_b16-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"Amado","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20230807130259_b17-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1200\/JCO.2008.20.8397","article-title":"Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer","volume":"27","author":"Bokemeyer","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20230807130259_b18-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"Douillard","year":"2013","journal-title":"N Engl J Med"},{"key":"key20230807130259_b19-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N Engl J Med"},{"key":"key20230807130259_b20-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/annonc\/mdu378","article-title":"Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: A meta-analysis of randomized, controlled trials","volume":"26","author":"Sorich","year":"2015","journal-title":"Ann Oncol"},{"key":"key20230807130259_b21-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2010.33.5091","article-title":"Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: Updated analysis of overall survival according to tumor KRAS and BRAF mutation status","volume":"29","author":"Van Cutsem","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20230807130259_b22-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(11)60613-2","article-title":"Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 MRC COIN trial","volume":"377","author":"Maughan","year":"2011","journal-title":"Lancet"},{"key":"key20230807130259_b23-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.19.02107","article-title":"Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164","volume":"38","author":"Le","year":"2020","journal-title":"J Clin Oncol"},{"key":"key20230807130259_b24-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-scale public data reuse to model immunotherapy response and resistance","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med"},{"key":"key20230807130259_b25-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat Med"},{"key":"key20230807130259_b26-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"key20230807130259_b27-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12967-020-02491-w","article-title":"Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment","volume":"18","author":"Wang","year":"2020","journal-title":"J Transl Med"},{"key":"key20230807130259_b28-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"4500561","DOI":"10.1155\/2023\/4500561","article-title":"Stem cell-associated signatures help to predict diagnosis and prognosis in ovarian serous cystadenocarcinoma","volume":"2023","author":"Li","year":"2023","journal-title":"Stem Cells Int"},{"key":"key20230807130259_b29-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"key20230807130259_b30-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"key20230807130259_b31-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","article-title":"Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data","volume":"11","author":"Finotello","year":"2019","journal-title":"Genome Med"},{"key":"key20230807130259_b32-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"key20230807130259_b33-ol-26-2-13946","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"key20230807130259_b34-ol-26-2-13946","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"key20230807130259_b35-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"key20230807130259_b36-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20230807130259_b37-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: Identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"key20230807130259_b38-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20230807130259_b39-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"key20230807130259_b40-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3748\/wjg.v29.i6.926","article-title":"Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments","volume":"29","author":"Tang","year":"2023","journal-title":"World J Gastroenterol"},{"key":"key20230807130259_b41-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.3390\/jcm8122168","article-title":"Basis of PD1\/PD-L1 Therapies","volume":"8","author":"Seliger","year":"2019","journal-title":"J Clin Med"},{"key":"key20230807130259_b42-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance mechanisms to immune-checkpoint blockade in cancer: Tumor-intrinsic and -extrinsic factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"key":"key20230807130259_b43-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity"},{"key":"key20230807130259_b44-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"key20230807130259_b45-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1200\/JCO.2017.74.3062","article-title":"Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: Two-Year outcomes from two randomized, open-label, phase III trials (CheckMate 017 and CheckMate 057)","volume":"35","author":"Horn","year":"2017","journal-title":"J Clin Oncol"},{"key":"key20230807130259_b46-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20230807130259_b47-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-Positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"key":"key20230807130259_b48-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"key20230807130259_b49-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40425-018-0367-1","article-title":"Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): Results from The Cancer Genome Atlas (TCGA)","volume":"6","author":"Danaher","year":"2018","journal-title":"J Immunother Cancer"},{"key":"key20230807130259_b50-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nature06309","article-title":"Adaptive immunity maintains occult cancer in an equilibrium state","volume":"450","author":"Koebel","year":"2007","journal-title":"Nature"},{"key":"key20230807130259_b51-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: From immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"key20230807130259_b52-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pag\u00e8s","year":"2005","journal-title":"N Engl J Med"},{"key":"key20230807130259_b53-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8(+) T cells: Foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"key":"key20230807130259_b54-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"a028480","DOI":"10.1101\/cshperspect.a028480","article-title":"Interferon \u03b3 and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity","volume":"11","author":"Alspach","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20230807130259_b55-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","article-title":"IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor","volume":"22","author":"Liu","year":"2021","journal-title":"Nat Immunol"},{"key":"key20230807130259_b56-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/imt-2018-0111","article-title":"Enhancing tumor T cell infiltration to enable cancer immunotherapy","volume":"11","author":"Zhang","year":"2019","journal-title":"Immunotherapy"},{"key":"key20230807130259_b57-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1252510","article-title":"The cellular and molecular origin of tumor-associated macrophages","volume":"344","author":"Franklin","year":"2014","journal-title":"Science"},{"key":"key20230807130259_b58-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/biom12030392","article-title":"Therapeutic approaches targeting proteins in tumor-associated macrophages and their applications in cancers","volume":"12","author":"Wu","year":"2022","journal-title":"Biomolecules"},{"key":"key20230807130259_b59-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/modpathol.2010.234","article-title":"Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor","volume":"24","author":"Dahlin","year":"2011","journal-title":"Mod Pathol"},{"key":"key20230807130259_b60-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1158\/0008-5472.CAN-12-2606","article-title":"PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer","volume":"73","author":"Badoual","year":"2013","journal-title":"Cancer Res"},{"key":"key20230807130259_b61-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/1078-0432.CCR-15-1543","article-title":"Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma","volume":"22","author":"Vassilakopoulou","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20230807130259_b62-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.2147\/OTT.S113307","article-title":"The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma","volume":"9","author":"Wang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20230807130259_b63-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1158\/1078-0432.CCR-06-2073","article-title":"High macrophage infiltration along the tumor front correlates with improved survival in colon cancer","volume":"13","author":"Forssell","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20230807130259_b64-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/ijms20020273","article-title":"Iron as a central player and promising target in cancer progression","volume":"20","author":"Jung","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20230807130259_b65-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: More ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"key20230807130259_b66-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ijms20010095","article-title":"Iron metabolism in cancer","volume":"20","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20230807130259_b67-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"e139434","DOI":"10.1172\/JCI139434","article-title":"TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis","volume":"131","author":"Jiang","year":"2021","journal-title":"J Clin Invest"},{"key":"key20230807130259_b68-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"key20230807130259_b69-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1182\/blood-2003-10-3366","article-title":"HAMPas a modifier gene that increases the phenotypic expression of the HFEpC282Y homozygous genotype","volume":"103","author":"Jacolot","year":"2004","journal-title":"Blood"},{"key":"key20230807130259_b70-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1182\/blood-2017-11-737411","article-title":"Hepcidin agonists as therapeutic tools","volume":"131","author":"Casu","year":"2018","journal-title":"Blood"},{"key":"key20230807130259_b71-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1182\/blood-2011-04-351957","article-title":"Hepcidin regulation by innate immune and infectious stimuli","volume":"118","author":"Armitage","year":"2011","journal-title":"Blood"},{"key":"key20230807130259_b72-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.aau6481","article-title":"Dendritic cell-derived hepcidin sequesters iron from the microbiota to promote mucosal healing","volume":"368","author":"Bessman","year":"2020","journal-title":"Science"},{"key":"key20230807130259_b73-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.biocel.2005.02.023","article-title":"Hepcidin: A direct link between iron metabolism and immunity","volume":"37","author":"Vyoral","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"key20230807130259_b74-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2013-07-515957","article-title":"Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras\/RAF and nutrient-dependent mTOR signaling","volume":"123","author":"Mleczko-Sanecka","year":"2014","journal-title":"Blood"},{"key":"key20230807130259_b75-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"7184760","DOI":"10.1155\/2021\/7184760","article-title":"The effects of dandelion polysaccharides on iron metabolism by regulating hepcidin via JAK\/STAT signaling pathway","volume":"2021","author":"Ren","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"key20230807130259_b76-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/biomedicines10010189","article-title":"Activation of STAT and SMAD signaling induces hepcidin re-expression as a therapeutic target for \u03b2-Thalassemia patients","volume":"10","author":"Saad","year":"2022","journal-title":"Biomedicines"},{"key":"key20230807130259_b77-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41416-022-01753-2","article-title":"Hepcidin in hepatocellular carcinoma","volume":"127","author":"Joachim","year":"2022","journal-title":"Br J Cancer"},{"key":"key20230807130259_b78-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jhep.2014.10.046","article-title":"Hepatic hepcidin expression is decreased in cirrhosis and HCC","volume":"62","author":"Kessler","year":"2015","journal-title":"J Hepatol"},{"key":"key20230807130259_b79-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/labinvest.2011.123","article-title":"Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma","volume":"91","author":"Maegdefrau","year":"2011","journal-title":"Lab Invest"},{"key":"key20230807130259_b80-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.21037\/atm.2018.10.30","article-title":"New highlight in breast cancer development: The key role of hepcidin and iron metabolism","volume":"6","author":"Scimeca","year":"2018","journal-title":"Ann Transl Med"},{"key":"key20230807130259_b81-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1158\/0008-5472.CAN-14-2465","article-title":"Hepcidin regulation in prostate and its disruption in prostate cancer","volume":"75","author":"Tesfay","year":"2015","journal-title":"Cancer Res"},{"key":"key20230807130259_b82-ol-26-2-13946","first-page":"9953","article-title":"Role of hepcidin and iron metabolism in the onset of prostate cancer","volume":"15","author":"Zhao","year":"2018","journal-title":"Oncol Lett"},{"key":"key20230807130259_b83-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/1759-7714.12046","article-title":"Increased hepcidin expression in non-small cell lung cancer tissue and serum is associated with clinical stage","volume":"5","author":"Chen","year":"2014","journal-title":"Thorac Cancer"},{"key":"key20230807130259_b84-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/nutrit\/nuaa040","article-title":"Iron deficiency, immunology, and colorectal cancer","volume":"79","author":"Phipps","year":"2021","journal-title":"Nutr Rev"},{"key":"key20230807130259_b85-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"OF2","DOI":"10.1158\/2159-8290.CD-RW2021-092","article-title":"Colorectal cancer cells ectopically express hepcidin to sequester iron","volume":"11","year":"2021","journal-title":"Cancer Discov"},{"key":"key20230807130259_b86-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s42255-021-00406-7","article-title":"Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells","volume":"3","author":"Schwartz","year":"2021","journal-title":"Nat Metab"},{"key":"key20230807130259_b87-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"109021","DOI":"10.1016\/j.cbi.2020.109021","article-title":"Iron and hepcidin mediate human colorectal cancer cell growth","volume":"319","author":"Sornjai","year":"2020","journal-title":"Chem Biol Interact"},{"key":"key20230807130259_b88-ol-26-2-13946","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1515\/med-2017-0027","article-title":"Expression of hepcidin and neogenin in colorectal cancer","volume":"12","author":"Xiang-Tao","year":"2017","journal-title":"Open Med (Wars)"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T10:07:49Z","timestamp":1691402869000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2023.13946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2023.13946","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"article-number":"360"}}